(Q40793421)

23 September 2017

title

Effect of Ang-2-VEGF-A Bispecific Antibody in Renal Cell Carcinoma (English)

1 reference

23 September 2017

5

0 references

Dachuan Huang

object named as

Dachuan Huang

3

0 references

Bin Tean Teh

object named as

Bin Tean Teh

10

0 references

author name string

Hideharu Bessho

1

1 reference

23 September 2017

Bernice Wong

2

1 reference

23 September 2017

Jing Tan

4

1 reference

23 September 2017

Masatsugu Iwamura

6

1 reference

23 September 2017

Stefan Hart

7

1 reference

23 September 2017

Markus Dangl

8

1 reference

23 September 2017

Markus Thomas

9

1 reference

23 September 2017

publication date

26 June 2015

1 reference

23 September 2017

1 reference

23 September 2017

volume

33

1 reference

23 September 2017

issue

8

1 reference

23 September 2017

page(s)

378-386

1 reference

Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial.

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2015.1047505

Angiogenesis: an organizing principle for drug discovery?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2015.1047505

Interaction between bevacizumab and murine VEGF-A: a reassessment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2015.1047505

Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2015.1047505

Inhibition of vascular endothelial growth factor reduces angiogenesis and modulates immune cell infiltration of orthotopic breast cancer xenografts.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2015.1047505

Double antiangiogenic protein, DAAP, targeting VEGF-A and angiopoietins in tumor angiogenesis, metastasis, and vascular leakage

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2015.1047505

Complementary actions of inhibitors of angiopoietin-2 and VEGF on tumor angiogenesis and growth

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2015.1047505

A novel angiopoietin-2 selective fully human antibody with potent anti-tumoral and anti-angiogenic efficacy and superior side effect profile compared to Pan-Angiopoietin-1/-2 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2015.1047505

Ang-2-VEGF-A CrossMab, a novel bispecific human IgG1 antibody blocking VEGF-A and Ang-2 functions simultaneously, mediates potent antitumor, antiangiogenic, and antimetastatic efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2015.1047505

Identification of serum angiopoietin-2 as a biomarker for clinical outcome of colorectal cancer patients treated with bevacizumab-containing therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2015.1047505

Immunoglobulin domain crossover as a generic approach for the production of bispecific IgG antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2015.1047505

Sunitinib acts primarily on tumor endothelium rather than tumor cells to inhibit the growth of renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2015.1047505

A simple method for measuring interstitial fluid pressure in cancer tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2015.1047505

High interstitial fluid pressure - an obstacle in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2015.1047505

TTF-1 and Napsin A double stain: a useful marker for diagnosing lung adenocarcinoma on fine-needle aspiration cell blocks.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2015.1047505

Inhibition of MAPK kinase signaling pathways suppressed renal cell carcinoma growth and angiogenesis in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2015.1047505

Summaries of Affymetrix GeneChip probe level data

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2015.1047505

A new mathematical model for relative quantification in real-time RT-PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2015.1047505

Chemical generation of bispecific antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2015.1047505

Targeting the ANG2/TIE2 axis inhibits tumor growth and metastasis by impairing angiogenesis and disabling rebounds of proangiogenic myeloid cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2015.1047505

Angiopoietin 2 expression in invasive ductal carcinoma of the breast: its relationship to the VEGF expression and microvessel density.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2015.1047505

Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2015.1047505

Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2015.1047505

Tumor interstitial fluid pressure as an early-response marker for anticancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2015.1047505

Host-derived angiopoietin-2 affects early stages of tumor development and vessel maturation but is dispensable for later stages of tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2015.1047505

Angiopoietin 2 displays a vascular endothelial growth factor dependent synergistic effect in hepatocellular carcinoma development in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2015.1047505

A human monoclonal anti-ANG2 antibody leads to broad antitumor activity in combination with VEGF inhibitors and chemotherapy agents in preclinical models

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2015.1047505

The Tie-2 ligand angiopoietin-2 destabilizes quiescent endothelium through an internal autocrine loop mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2015.1047505

Interstitial fluid pressure is increased in renal cell carcinoma xenografts.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2015.1047505

Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2015.1047505

10.3109/07357907.2015.1047505

21 January 2018

Identifiers

DOI

1 reference

23 September 2017

1 reference